Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Dev Neurobiol ; 72(6): 805-20, 2012 Jun.
Article in English | MEDLINE | ID: mdl-21913335

ABSTRACT

Gamma-aminobutyric acid (GABA) ergic interneurons are lost in conditions including epilepsy and central nervous system injury, but there are few culture models available to study their function. Toward the goal of obtaining renewable sources of GABAergic neurons, we used the molecular profile of a functionally incomplete GABAergic precursor clone to screen 17 new clones isolated from GFP(+) rat E14.5 cortex and ganglionic eminence (GE) that were generated by viral introduction of v-myc. The clones grow as neurospheres in medium with FGF2, and after withdrawal of FGF2, they exhibit varying patterns of differentiation. Transcriptional profiling and quantitative reverse transcriptase polymerase chain reaction (RT-PCR) indicated that one clone (GE6) expresses high levels of mRNAs encoding Dlx1, 2, 5, and 6, glutamate decarboxylases, and presynaptic proteins including neuropeptide Y and somatostatin. Protein expression confirmed that GE6 is a progenitor with restricted differentiation giving rise mostly to neurons with GABAergic markers. In cocultures with hippocampal neurons, GE6 neurons became electrically excitable and received both inhibitory and excitatory synapses. After withdrawal of FGF2 in cultures of GE6 alone, neurons matured to express ßIII-tubulin, and staining for synaptophysin and vesicular GABA transporter were robust after 1-2 weeks of differentiation. GE6 neurons also became electrically excitable and displayed synaptic activity, but synaptic currents were carried by chloride and were blocked by bicuculline. The results suggest that the GE6 clone, which is ventrally derived from the GE, resembles GABAergic interneuron progenitors that migrate into the developing forebrain. This is the first report of a relatively stable fetal clone that can be differentiated into GABAergic interneurons with functional synapses.


Subject(s)
Cerebral Cortex/cytology , GABAergic Neurons/cytology , Homeodomain Proteins/metabolism , Neural Stem Cells/cytology , Neurogenesis/physiology , Transcription Factors/metabolism , Animals , Cells, Cultured , Cerebral Cortex/metabolism , GABAergic Neurons/metabolism , Gene Expression Profiling , Homeodomain Proteins/genetics , Neural Stem Cells/metabolism , Rats , Transcription Factors/genetics
2.
Curr Biol ; 19(24): 2091-6, 2009 Dec 29.
Article in English | MEDLINE | ID: mdl-19962314

ABSTRACT

ATM is a PI 3-kinase involved in DNA double-strand break repair. ATM deficiency leads to ataxia-telangiectasia (A-T), a syndrome of cancer susceptibility, hypersensitivity to ionizing radiation, immune deficiency, and sterility [1, 2]-phenotypes that can straightforwardly be attributed to a defective response to DNA damage. Yet patients with A-T also suffer from ataxia, speech defects, and abnormal body movements [3-5]-neurological phenotypes whose origins remain largely unexplained. Compounding the discordance, Atm mutations in mouse interfere with DNA repair but have only mild neurological symptoms [6-9], suggesting that the link between DNA damage and the death of neurons can be broken [10-12]. We find that in neurons, ATM protein has a substantial cytoplasmic distribution. We show that in Atm(tm1Awb) mice, hippocampal long-term potentiation is significantly reduced, as is the rate of spontaneous vesicular dye release, suggesting a functional importance of cytoplasmic ATM. In the cytoplasm, ATM forms a complex with two synaptic vesicle proteins, VAMP2 and synapsin-I, both of which must be phosphorylated to bind ATM. Also, cytoplasmic ATM physically associates with the homologous PI 3-kinase, ATR. The neurological symptoms of ataxia-telangiectasia may thus result from defective nonnuclear functions of ATM not associated with DNA repair.


Subject(s)
Ataxia Telangiectasia/metabolism , Cell Cycle Proteins/metabolism , Cytoplasm/enzymology , DNA Damage/physiology , DNA-Binding Proteins/metabolism , Hippocampus/physiology , Neurons/enzymology , Protein Serine-Threonine Kinases/metabolism , Synapses/physiology , Tumor Suppressor Proteins/metabolism , Animals , Ataxia Telangiectasia/pathology , Ataxia Telangiectasia Mutated Proteins , Excitatory Postsynaptic Potentials , Long-Term Potentiation , Mice , Microscopy, Fluorescence , Phosphorylation , RNA, Small Interfering/genetics , Synapsins/metabolism , Vesicle-Associated Membrane Protein 2/metabolism
3.
J Neurophysiol ; 100(6): 3264-74, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18842955

ABSTRACT

Brain-derived neurotrophic factor (BDNF), a potent modulator of synaptic transmission, is known to influence associative synaptic plasticity and refinement of neural connectivity. We now show that BDNF modulation of glutamate currents in hippocampal neurons exhibits the additional property of use dependence, a postsynaptic mechanism resulting in selective modulation of active channels. We demonstrate selectivity by varying the repetition rate of iontophoretically applied glutamate pulses during BDNF exposure. During relatively high-frequency glutamate pulses (0.1 Hz), BDNF application elicited a doubling of the glutamate current. During low-frequency pulses (0.0033 Hz), however, BDNF evoked a dramatically diminished response. This effect was apparently mediated by calcium because manipulations that prevented elevation of intracellular calcium largely eliminated the action of BDNF on glutamate currents. To confirm N-methyl-D-aspartate (NMDA) receptor involvement and assess spatial requirements, we made cell-attached single-channel recordings from somatic NMDA receptors. Inclusion of calcium in the pipette was sufficient to produce enhancement of channel activity by BDNF. Substitution of EGTA for calcium prevented BDNF effects. We conclude that BDNF modulation of postsynaptic NMDA receptors requires concurrent neuronal activity potentially conferring synaptic specificity on the neurotrophin's actions.


Subject(s)
Brain-Derived Neurotrophic Factor/pharmacology , Membrane Potentials/drug effects , Neurons/drug effects , Receptors, N-Methyl-D-Aspartate/physiology , Animals , Biophysics , Calcium/pharmacology , Cells, Cultured , Chelating Agents/pharmacology , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Electric Stimulation , Embryo, Mammalian , Excitatory Amino Acid Antagonists/pharmacology , Female , Glutamic Acid/pharmacology , Hippocampus/cytology , Ion Channel Gating/drug effects , Iontophoresis/methods , Kynurenic Acid/pharmacology , Membrane Potentials/physiology , Neurons/physiology , Patch-Clamp Techniques/methods , Pregnancy , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/drug effects
4.
Dev Neurobiol ; 68(14): 1549-64, 2008 Dec.
Article in English | MEDLINE | ID: mdl-18814314

ABSTRACT

We have generated clones (L2.3 and RG3.6) of neural progenitors with radial glial properties from rat E14.5 cortex that differentiate into astrocytes, neurons, and oligodendrocytes. Here, we describe a different clone (L2.2) that gives rise exclusively to neurons, but not to glia. Neuronal differentiation of L2.2 cells was inhibited by bone morphogenic protein 2 (BMP2) and enhanced by Sonic Hedgehog (SHH) similar to cortical interneuron progenitors. Compared with L2.3, differentiating L2.2 cells expressed significantly higher levels of mRNAs for glutamate decarboxylases (GADs), DLX transcription factors, calretinin, calbindin, neuropeptide Y (NPY), and somatostatin. Increased levels of DLX-2, GADs, and calretinin proteins were confirmed upon differentiation. L2.2 cells differentiated into neurons that fired action potentials in vitro, and their electrophysiological differentiation was accelerated and more complete when cocultured with developing astroglial cells but not with conditioned medium from these cells. The combined results suggest that clone L2.2 resembles GABAergic interneuron progenitors in the developing forebrain.


Subject(s)
Cell Differentiation/physiology , Cerebral Cortex/cytology , Embryonic Stem Cells/physiology , Gene Expression/physiology , Interneurons/physiology , Action Potentials/genetics , Action Potentials/physiology , Animals , Bone Morphogenetic Protein 2/pharmacology , Cell Differentiation/drug effects , Cell Separation , Cells, Cultured , Cerebral Cortex/embryology , Clone Cells , Culture Media, Conditioned/pharmacology , Embryo, Mammalian , Embryonic Stem Cells/drug effects , Fibroblast Growth Factor 2/pharmacology , Gene Expression/drug effects , Magnetics , Nerve Tissue Proteins/metabolism , Patch-Clamp Techniques/methods , Rats , Tubulin/metabolism
5.
J Neurosci ; 27(27): 7339-43, 2007 Jul 04.
Article in English | MEDLINE | ID: mdl-17611286

ABSTRACT

The identity of any cell type is determined by the specific pattern of gene expression. We show here that the ability of oligodendrocyte progenitors to acquire the identity of myelin-expressing cells or choose alternative fates is dependent on the activity of histone deacetylases. Using gene expression profiling, electrophysiological recordings, transplantation studies, and pharmacological inhibition, we demonstrate that specified NG2+ oligodendrocyte progenitors are plastic cells, whose decision to initiate an oligodendrocytic rather than astrocytic or neuronal program of gene expression requires the establishment of an epigenetic identity that is initiated by histone deacetylation.


Subject(s)
Epigenesis, Genetic/physiology , Neuroglia/physiology , Neurons/physiology , Oligodendroglia/physiology , Stem Cells/physiology , Animals , Animals, Newborn , Cells, Cultured , Histone Deacetylases/metabolism , Histone Deacetylases/physiology , Histones/metabolism , Memory/physiology , Neuroglia/cytology , Neuroglia/enzymology , Neuroglia/transplantation , Neurons/cytology , Neurons/enzymology , Neurons/transplantation , Oligodendroglia/cytology , Oligodendroglia/enzymology , Oligodendroglia/transplantation , Rats , Stem Cells/cytology , Stem Cells/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...